Jiangsu Hengrui Medicine Co Ltd (600276.SS)

600276.SS on Shanghai Stock Exchange

19 Dec 2014
Price Change (% chg)

¥-0.44 (-1.16%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for 600276.SS


JIANGSU HENGRUI MEDICINE CO., LTD. is principally engaged in the manufacturing and distribution of pharmaceutical tablets, injections and raw materials. The Company’s main products portfolio consists of antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, drugs for the treatment of endocrine, antibiotics, infusions... (more)


Beta: 0.18
Market Cap (Mil.): ¥56,219.25
Shares Outstanding (Mil.): 1,503.99
Dividend: --
Yield (%): 0.22


  600276.SS Industry Sector
P/E (TTM): 39.16 37.83 38.47
EPS (TTM): 0.95 -- --
ROI: 22.05 18.99 18.25
ROE: 21.10 19.75 19.13
Search Stocks

BRIEF-U.S. prosecutors withdraw allegations on scientists selling trade secrets to Hengrui Medicine

* Says U.S. prosecutors withdrew allegations that two ex-Eli Lilly's scientists sold trade secrets worth $50 million to the company

08 Dec 2014

BRIEF-Jiangsu Hengrui Medicine board agrees to set up unit in Germany

Further company coverage: (Reporting by Hong Kong and Singapore newsrooms)

11 Nov 2014

BRIEF-Jiangsu Hengrui Medicine's 9-mth net profit up 20.7 pct

* Says 9-month net profit up 20.7 percent y/y at 1.1 billion yuan(179.86 million US dollar)

27 Oct 2014

BRIEF-Jiangsu Hengrui Medicine's H1 net profit up 18.4 pct

* Says H1 net profit up 18.4 percent y/y at 760 million yuan(123.60 million US dollar)

15 Aug 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: GlobalData
Provider: Thomson Reuters Stock Report
Provider: Reuters Investment Profile
Provider: Wright Reports
Provider: Sadif Analytics Prime

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks